Theseus Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatm…

Biotechnology
US, Cambridge [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of THRX's Analysis
CIK: 1745020 CUSIP: 88369M101 ISIN: US88369M1018 LEI: - UEI: -
Secondary Listings
THRX has no secondary listings inside our databases.